2020
DOI: 10.1016/j.idcr.2020.e00857
|View full text |Cite
|
Sign up to set email alerts
|

Mycetoma due to Madurella mycetomatis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 12 publications
0
4
0
Order By: Relevance
“…Eumycetoma pedis is a neglected tropical disease with more predilection among individuals frequently exposed to the agricultural environment, such as farmers. Hence, about 70-75% of patients have initial lesions affecting the lower extremities, typically occurring in adult male ranging from 20 to 40 years of age [6]. The clinical manifestation often starts as a small, painless, subcutaneous nodule at the site of a traumatized skin.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Eumycetoma pedis is a neglected tropical disease with more predilection among individuals frequently exposed to the agricultural environment, such as farmers. Hence, about 70-75% of patients have initial lesions affecting the lower extremities, typically occurring in adult male ranging from 20 to 40 years of age [6]. The clinical manifestation often starts as a small, painless, subcutaneous nodule at the site of a traumatized skin.…”
Section: Discussionmentioning
confidence: 99%
“…Occasionally reported, mycetoma pedis also appears from Indonesia as a tropical country, but unfortunately, the data are still limited [5]. Madurella mycetomatis is known as the most common fungal causative agent in eumycetoma pedis [6]. The treatment of eumycetoma is challenging and mostly unsatisfactory, as most of the cases require not only pharmacologic approaches but also should be combined with surgical intervention.…”
Section: Introductionmentioning
confidence: 99%
“…The clinical presentation of a Madura foot caused by Madurella mycetomatis is similar between immunocompromised and immunocompetent patients (Fasciana et al, 2018;Karrakchou et al, 2020;Meis et al, 2000;Asly et al, 2010;Brufman et al, 2015;Mestre et al, 2015;Sigera et al, 2020;Fida et al, 2018;Elmaataoui et al, 2011;Sampaio et al, 2015;Sharma et al, 2012;Cunha et al, 2018). However, immunocompromised patients are more likely to have a severe infection than patients who are immunocompetent, due to a weakened immune system (Knott, 2015).…”
Section: Immunocompromised Versus Immunocompetent Patientsmentioning
confidence: 99%
“…Many studies describing mycetoma infections in immunocompetent patients have been published (Fasciana et al, 2018;Karrakchou et al, 2020;Asly et al, 2010;Brufman et al, 2015;Mestre et al, 2015;Sigera et al, 2020;Fida et al, 2018;Elmaataoui et al, 2011;Sampaio et al, 2015). However, studies reporting on mycetoma infections in immunocompromised patients are rare.…”
Section: Introductionmentioning
confidence: 99%